{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:02:06Z","timestamp":1793052126029,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFD1800200"],"award-info":[{"award-number":["2022YFD1800200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijpddr.2025.100601","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:49:41Z","timestamp":1749066581000},"page":"100601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Type A asparagine synthetase in the zoonotic Cryptosporidium parvum (CpAsnA): Biochemical features and potential as a novel therapeutic target"],"prefix":"10.1016","volume":"28","author":[{"given":"Zongzhen","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-0659","authenticated-orcid":false,"given":"Guan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2025.100601_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1126\/science.1094786","article-title":"Complete genome sequence of the apicomplexan, Cryptosporidium parvum","volume":"304","author":"Abrahamsen","year":"2004","journal-title":"Science (Wash. D C)"},{"key":"10.1016\/j.ijpddr.2025.100601_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/1078-0432.CCR-14-1714","article-title":"Asparagine synthetase polymorphisms and toxicity and efficacy of asparaginases","volume":"21","author":"Avramis","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijpddr.2025.100601_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1101\/gr.275325.121","article-title":"Long-read assembly and comparative evidence-based reanalysis of Cryptosporidium genome sequences reveal expanded transporter repertoire and duplication of entire chromosome ends including subtelomeric regions","volume":"32","author":"Baptista","year":"2022","journal-title":"Genome Res."},{"key":"10.1016\/j.ijpddr.2025.100601_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(14)70772-8","article-title":"A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium","volume":"15","author":"Checkley","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100601_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpddr.2024.100551","article-title":"Lower micromolar activity of the antifungal imidazoles on the bacterial-type bifunctional aldehyde\/alcohol dehydrogenase (AdhE) in Cryptosporidium parvum and in vitro efficacy against the zoonotic parasite","volume":"25","author":"Chen","year":"2024","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2025.100601_bib6","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1021\/jm060943s","article-title":"Cinnamoyl compounds as simple molecules that inhibit p300 histone acetyltransferase","volume":"50","author":"Costi","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2025.100601_bib7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/acsmedchemlett.8b00081","article-title":"Homogeneous assay for target engagement utilizing bioluminescent thermal shift","volume":"9","author":"Dart","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ijpddr.2025.100601_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/jb.142.1.221-228.1980","article-title":"Mutations in two unlinked genes are required to produce asparagine auxotrophy in Escherichia coli","volume":"142","author":"Felton","year":"1980","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijpddr.2025.100601_bib9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.pt.2018.07.009","article-title":"Genetic diversity and population structure of cryptosporidium","volume":"34","author":"Feng","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100601_bib10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jit645","article-title":"Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases","volume":"209","author":"Guo","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100601_bib11","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/infdis\/jix689","article-title":"The existing drug vorinostat as a new lead against cryptosporidiosis by targeting the parasite histone deacetylases","volume":"217","author":"Guo","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100601_bib12","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1021\/acs.jmedchem.9b00069","article-title":"Development of 5-Aminopyrazole-4-carboxamide-based bumped-kinase inhibitors for cryptosporidiosis therapy","volume":"62","author":"Huang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2025.100601_bib13","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1021\/acs.jmedchem.5b01267","article-title":"4-Acyl pyrrole derivatives yield novel vectors for designing inhibitors of the acetyl-lysine recognition site of BRD4(1)","volume":"59","author":"Hugle","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2025.100601_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/0471140864.ps2809s79","article-title":"Analysis of protein stability and ligand interactions by thermal shift assay","volume":"79","author":"Huynh","year":"2015","journal-title":"Curr Protoc Protein Sci"},{"key":"10.1016\/j.ijpddr.2025.100601_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.pt.2019.12.016","article-title":"A one health approach to tackle cryptosporidiosis","volume":"36","author":"Innes","year":"2020","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100601_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1115522","article-title":"Past, current, and potential treatments for cryptosporidiosis in humans and farm animals: a comprehensive review","volume":"13","author":"Khan","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijpddr.2025.100601_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11020061","article-title":"Amino acid metabolism in apicomplexan parasites","volume":"11","author":"Krishnan","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.ijpddr.2025.100601_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.azn.2024.06.001","article-title":"Thermal shift assay (TSA)-based drug screening strategy for rapid discovery of inhibitors against the Nsp13 helicase of SARS-CoV-2","volume":"1","author":"Li","year":"2025","journal-title":"Animals and Zoonoses"},{"key":"10.1016\/j.ijpddr.2025.100601_bib19","doi-asserted-by":"crossref","first-page":"19952","DOI":"10.1074\/jbc.R117.819060","article-title":"Asparagine synthetase: function, structure, and role in disease","volume":"292","author":"Lomelino","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2025.100601_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.747404","article-title":"Synthesis of L-asparagine catalyzed by a novel asparagine synthase coupled with an ATP regeneration System","volume":"9","author":"Luo","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijpddr.2025.100601_bib21","doi-asserted-by":"crossref","first-page":"12096","DOI":"10.1074\/jbc.M114.554642","article-title":"Identification and functional characterization of a novel bacterial type asparagine synthetase A: a tRNA synthetase paralog from Leishmania donovani","volume":"289","author":"Manhas","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2025.100601_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature22337","article-title":"A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis","volume":"546","author":"Manjunatha","year":"2017","journal-title":"Nature (London)"},{"key":"10.1016\/j.ijpddr.2025.100601_bib23","doi-asserted-by":"crossref","first-page":"8775","DOI":"10.1038\/ncomms9775","article-title":"Asparagine requirement in Plasmodium berghei as a target to prevent malaria transmission and liver infections","volume":"6","author":"Nagaraj","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpddr.2025.100601_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1107\/S0907444996000236","article-title":"Crystallization and preliminary crystallographic study of asparagine synthetase from Escherichia coli","volume":"52","author":"Nakatsu","year":"1996","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.ijpddr.2025.100601_bib25","article-title":"Targeting members of the chemokine family as a novel approach to treating neuropathic pain","volume":"28","author":"Pawlik","year":"2023","journal-title":"Molecules (Basel)"},{"key":"10.1016\/j.ijpddr.2025.100601_bib26","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1128\/jb.151.3.1299-1313.1982","article-title":"Asparagine synthetases of Klebsiella aerogenes: properties and regulation of synthesis","volume":"151","author":"Reitzer","year":"1982","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijpddr.2025.100601_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.exppara.2008.12.014","article-title":"Cryptosporidium: genomic and biochemical features","volume":"124","author":"Rider","year":"2010","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100601_bib28","article-title":"Study of the economic impact of cryptosporidiosis in calves after implementing good practices to manage the disease on dairy farms in Belgium, France, and The Netherlands","volume":"4","author":"Roblin","year":"2023","journal-title":"Curr Res Parasitol Vector Borne Dis"},{"key":"10.1016\/j.ijpddr.2025.100601_bib29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/pim.12350","article-title":"Cryptosporidium in humans and animals-a one health approach to prophylaxis","volume":"38","author":"Ryan","year":"2016","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ijpddr.2025.100601_bib30","doi-asserted-by":"crossref","first-page":"14620","DOI":"10.1021\/acs.jmedchem.1c01119","article-title":"4-Acyl pyrrole capped HDAC inhibitors: a new scaffold for hybrid inhibitors of BET proteins and histone deacetylases as antileukemia drug leads","volume":"64","author":"Schaker-Hubner","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2025.100601_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijpara.2020.03.002","article-title":"Long-term production effects of clinical cryptosporidiosis in neonatal calves","volume":"50","author":"Shaw","year":"2020","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100601_bib32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/10409238.2017.1290043","article-title":"Genomics of apicomplexan parasites","volume":"52","author":"Swapna","year":"2017","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.ijpddr.2025.100601_bib33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ijpara.2006.02.023","article-title":"Quantitative and qualitative comparisons of Cryptosporidium faecal purification procedures for the isolation of oocysts suitable for proteomic analysis","volume":"36","author":"Truong","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2025.100601_bib34","doi-asserted-by":"crossref","first-page":"10095","DOI":"10.1074\/jbc.273.17.10095","article-title":"Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration","volume":"273","author":"White","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2025.100601_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/jac\/dkab369","article-title":"Host cells with transient overexpression of MDR1 as a novel in vitro model for evaluating on-target effect for activity against the epicellular Cryptosporidium parasite","volume":"77","author":"Yang","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2025.100601_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/jac\/dkab369","article-title":"Host cells with transient overexpression of as a novel model for evaluating on-target effect for activity against the epicellular parasite","volume":"77","author":"Yang","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2025.100601_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011217","article-title":"On-target inhibition of Cryptosporidium parvum by nitazoxanide (NTZ) and paclitaxel (PTX) validated using a novel MDR1-transgenic host cell model and algorithms to quantify the effect on the parasite target","volume":"17","author":"Yang","year":"2023","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2025.100601_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-1-4939-9748-0_18","article-title":"High-throughput screening of drugs against the growth of Cryptosporidium parvum in vitro by qRT-PCR","volume":"2052","author":"Zhang","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijpddr.2025.100601_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s44149-021-00002-y","article-title":"Current status and challenges in drug discovery against the globally important zoonotic cryptosporidiosis","volume":"1","author":"Zhu","year":"2021","journal-title":"Animal Diseases"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T07:56:12Z","timestamp":1754985372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320725000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":39,"alternative-id":["S2211320725000247"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100601","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type A asparagine synthetase in the zoonotic Cryptosporidium parvum (CpAsnA): Biochemical features and potential as a novel therapeutic target","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"100601"}}